Skip to main content
Top
Published in: Familial Cancer 1/2020

Open Access 01-01-2020 | Chondrosarcoma | Short Communication

Clear cell chondrosarcoma in Von Hippel-Lindau disease

Authors: Koen M. A. Dreijerink, Rachel S. van Leeuwaarde, Wenzel M. Hackeng, Rachel H. Giles, Wendy W. J. de Leng, Paul C. Jutte, Albert J. H. Suurmeijer, Bernadette P. M. van Nesselrooij, Lodewijk A. A. Brosens

Published in: Familial Cancer | Issue 1/2020

Login to get access

Abstract

A diagnosis of clear cell chondrosarcoma of the ulna was made in a patient with Von Hippel-Lindau disease (VHL). After surgery, genetic analysis of the tumor tissue showed loss of heterozygosity at the VHL gene locus. Immunohistochemical analysis confirmed loss of expression of the VHL protein in the tumor cells. In addition, abundant Cyclin D1 expression in the tumor was observed. Chondrosarcoma has been described before in a VHL patient and VHL protein expression has been correlated to tumor grade in a series of sporadic chondrosarcomas. In this report, we show that clear cell chondrosarcoma may be a rare but canonical VHL manifestation through a cell-autonomous mechanism involving somatic loss-of-heterozygosity of the VHL tumor suppressor gene. We discuss the relevance of this observation with regard to the pathogenesis of clear cell chondrosarcoma in the context of VHL.
Literature
1.
go back to reference Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L et al (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260(5112):1317–1320CrossRef Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L et al (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260(5112):1317–1320CrossRef
4.
go back to reference Fletcher CDM, World Health Organization, International Agency for Research on Cancer (2013) WHO classification of tumours of soft tissue and bone. World Health Organization classification of tumours, 4th edn. IARC Press, Lyon Fletcher CDM, World Health Organization, International Agency for Research on Cancer (2013) WHO classification of tumours of soft tissue and bone. World Health Organization classification of tumours, 4th edn. IARC Press, Lyon
5.
go back to reference Tarpey PS, Behjati S, Cooke SL, Van Loo P, Wedge DC, Pillay N, Marshall J, O’Meara S, Davies H, Nik-Zainal S, Beare D, Butler A, Gamble J, Hardy C, Hinton J, Jia MM, Jayakumar A, Jones D, Latimer C, Maddison M, Martin S, McLaren S, Menzies A, Mudie L, Raine K, Teague JW, Tubio JM, Halai D, Tirabosco R, Amary F, Campbell PJ, Stratton MR, Flanagan AM, Futreal PA (2013) Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat Genet 45(8):923–926. https://doi.org/10.1038/ng.2668 CrossRefPubMedPubMedCentral Tarpey PS, Behjati S, Cooke SL, Van Loo P, Wedge DC, Pillay N, Marshall J, O’Meara S, Davies H, Nik-Zainal S, Beare D, Butler A, Gamble J, Hardy C, Hinton J, Jia MM, Jayakumar A, Jones D, Latimer C, Maddison M, Martin S, McLaren S, Menzies A, Mudie L, Raine K, Teague JW, Tubio JM, Halai D, Tirabosco R, Amary F, Campbell PJ, Stratton MR, Flanagan AM, Futreal PA (2013) Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat Genet 45(8):923–926. https://​doi.​org/​10.​1038/​ng.​2668 CrossRefPubMedPubMedCentral
6.
go back to reference Marinozzi A, Papapietro N, Barnaba SA, Di Martino A, Tonini G, Denaro V (2007) Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease. J Exp Clin Cancer Res 26(4):599–601PubMed Marinozzi A, Papapietro N, Barnaba SA, Di Martino A, Tonini G, Denaro V (2007) Chondrosarcoma of the iliac wing in Von Hippel-Lindau disease. J Exp Clin Cancer Res 26(4):599–601PubMed
Metadata
Title
Clear cell chondrosarcoma in Von Hippel-Lindau disease
Authors
Koen M. A. Dreijerink
Rachel S. van Leeuwaarde
Wenzel M. Hackeng
Rachel H. Giles
Wendy W. J. de Leng
Paul C. Jutte
Albert J. H. Suurmeijer
Bernadette P. M. van Nesselrooij
Lodewijk A. A. Brosens
Publication date
01-01-2020
Publisher
Springer Netherlands
Keyword
Chondrosarcoma
Published in
Familial Cancer / Issue 1/2020
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-019-00149-1

Other articles of this Issue 1/2020

Familial Cancer 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine